Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pds Biotechnology Corp (PDSB) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pds Biotechnology Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1472091.
Total stock buying since 2015: $15,334,239.
Total stock sales since 2015: $1,496,014.
Total stock option exercises since 2015: $495,093.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 30,121 | $50,000 | 0 | $0 | 0 | $0 |
| 2021 | 18,982 | $176,599 | 0 | $0 | 56,144 | $367,143 |
| 2019 | 0 | $0 | 0 | $0 | 401,797 | $0 |
| 2018 | 0 | $0 | 45,000 | $648,025 | 0 | $0 |
| 2017 | 3,000 | $27,720 | 59,461 | $612,564 | 25,000 | $51,000 |
| 2016 | 554,343 | $4,069,470 | 22,500 | $235,425 | 15,000 | $76,950 |
| 2015 | 1,000,950 | $11,010,450 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-02 | 30,121 | $50,000 | 0 | $0 | 0 | $0 |
| 2021-12 | 3,100 | $27,822 | 0 | $0 | 0 | $0 |
| 2021-06 | 15,882 | $148,777 | 0 | $0 | 56,144 | $367,143 |
| 2019-03 | 0 | $0 | 0 | $0 | 401,797 | $0 |
| 2018-03 | 0 | $0 | 17,500 | $281,050 | 0 | $0 |
| 2018-02 | 0 | $0 | 22,500 | $316,425 | 0 | $0 |
| 2018-01 | 0 | $0 | 5,000 | $50,550 | 0 | $0 |
| 2017-12 | 0 | $0 | 7,500 | $73,925 | 0 | $0 |
| 2017-11 | 0 | $0 | 10,861 | $115,410 | 0 | $0 |
| 2017-10 | 0 | $0 | 7,500 | $82,200 | 0 | $0 |
| 2017-09 | 0 | $0 | 7,500 | $76,549 | 0 | $0 |
| 2017-08 | 0 | $0 | 11,000 | $115,390 | 0 | $0 |
| 2017-07 | 0 | $0 | 7,500 | $76,400 | 0 | $0 |
| 2017-04 | 0 | $0 | 100 | $1,110 | 0 | $0 |
| 2017-03 | 3,000 | $27,720 | 0 | $0 | 0 | $0 |
| 2017-02 | 0 | $0 | 7,500 | $71,580 | 0 | $0 |
| 2017-01 | 0 | $0 | 0 | $0 | 25,000 | $51,000 |
| 2016-12 | 0 | $0 | 7,500 | $87,000 | 0 | $0 |
| 2016-10 | 0 | $0 | 7,500 | $76,845 | 0 | $0 |
| 2016-08 | 10,000 | $94,792 | 7,500 | $71,580 | 0 | $0 |
| 2016-06 | 0 | $0 | 0 | $0 | 15,000 | $76,950 |
| 2016-03 | 544,343 | $3,974,678 | 0 | $0 | 0 | $0 |
| 2015-10 | 1,000,950 | $11,010,450 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-28 | Freitag Gregory Gene | Buy | 15,060 | 1.66 | 24,999 |
| 2025-02-28 | Glover Stephen C. | Buy | 15,061 | 1.66 | 25,001 |
| 2021-12-13 | Hill Matthew C (Chief Financial Officer) | Buy | 3,100 | 8.97 | 27,822 |
| 2021-06-16 | Bloomquist Delyle W | Buy | 10,000 | 9.88 | 98,780 |
| 2021-06-16 | Bloomquist Delyle W | Option Ex | 2,970 | 5.99 | 17,790 |
| 2021-06-15 | Bedu-addo Frank (President/CEO) | Option Ex | 53,174 | 6.57 | 349,353 |
| 2021-06-15 | Glover Steve C | Buy | 5,882 | 8.50 | 49,997 |
| 2019-03-15 | Macdonald R. Loch (Director) | Option Ex | 10,000 | .00 | 0 |
| 2019-03-15 | Leuthner Brian A (President and CEO) | Option Ex | 169,032 | .00 | 0 |
| 2019-03-15 | Saik Andrew (Chief Financial Officer) | Option Ex | 82,999 | .00 | 0 |
| 2019-03-15 | Ratcliffe Liam (Director) | Option Ex | 10,000 | .00 | 0 |
| 2019-03-15 | Spiegel Robert J. (Director) | Option Ex | 10,000 | .00 | 0 |
| 2019-03-15 | Crane Rosemary A (Director) | Option Ex | 10,000 | .00 | 0 |
| 2019-03-15 | Loughlin James J (Director) | Option Ex | 10,000 | .00 | 0 |
| 2019-03-15 | Barer Sol J (Director) | Option Ex | 20,000 | .00 | 0 |
| 2019-03-15 | Middlekauff W Bradford (Senior VP, GC and Secretary) | Option Ex | 49,766 | .00 | 0 |
| 2019-03-15 | Blech Isaac (Director) | Option Ex | 20,000 | .00 | 0 |
| 2018-03-22 | Macdonald R. Loch (Chief Scientific Officer) | Sale | 2,500 | 16.41 | 41,025 |
| 2018-03-21 | Macdonald R. Loch (Chief Scientific Officer) | Sale | 2,500 | 16.52 | 41,300 |
| 2018-03-20 | Macdonald R. Loch (Chief Scientific Officer) | Sale | 5,000 | 16.47 | 82,350 |
| 2018-03-19 | Macdonald R. Loch (Chief Scientific Officer) | Sale | 2,500 | 16.66 | 41,650 |
| 2018-03-02 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 15.08 | 37,700 |
| 2018-03-01 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 14.81 | 37,025 |
| 2018-02-23 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 15.37 | 38,425 |
| 2018-02-22 | Macdonald R. Loch (Chief Scientific Officer) | Sale | 2,500 | 14.49 | 36,225 |
| 2018-02-22 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 15.47 | 38,675 |
| 2018-02-21 | Macdonald R. Loch (Chief Scientific Officer) | Sale | 5,000 | 13.82 | 69,100 |
| 2018-02-20 | Macdonald R. Loch (Chief Scientific Officer) | Sale | 5,000 | 13.75 | 68,750 |
| 2018-02-02 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 12.96 | 32,400 |
| 2018-02-01 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 13.14 | 32,850 |
| 2018-01-03 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.11 | 25,275 |
| 2018-01-02 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.11 | 25,275 |
| 2017-12-05 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 9.68 | 24,200 |
| 2017-12-04 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 9.97 | 24,925 |
| 2017-12-01 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 9.92 | 24,800 |
| 2017-11-22 | Marchio Albert N Ii (Chief Accounting & Adm Officer) | Sale | 3,361 | 10.00 | 33,610 |
| 2017-11-03 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.86 | 27,150 |
| 2017-11-02 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.94 | 27,350 |
| 2017-11-01 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.92 | 27,300 |
| 2017-10-04 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 11.14 | 27,850 |
| 2017-10-03 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.93 | 27,325 |
| 2017-10-02 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.81 | 27,025 |
| 2017-09-06 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.31 | 25,775 |
| 2017-09-05 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 9.94 | 24,850 |
| 2017-09-01 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.37 | 25,924 |
| 2017-08-29 | Marchio Albert N Ii (Chief Accounting & Adm Officer) | Sale | 2,500 | 10.42 | 26,050 |
| 2017-08-23 | Marchio Albert N Ii (Chief Accounting & Adm Officer) | Sale | 1,000 | 10.39 | 10,390 |
| 2017-08-03 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.40 | 26,000 |
| 2017-08-02 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.53 | 26,325 |
| 2017-08-01 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.65 | 26,625 |
| 2017-07-06 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.08 | 25,200 |
| 2017-07-05 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.21 | 25,525 |
| 2017-07-03 | Leuthner Brian A (President and CEO) | Sale | 2,500 | 10.27 | 25,675 |
| 2017-04-26 | Leuthner Brian A (President and CEO) | Sale | 100 | 11.10 | 1,110 |
| 2017-03-06 | Loughlin James J (Director) | Buy | 3,000 | 9.24 | 27,720 |
| 2017-02-07 | Leuthner Brian A (President and CEO) | Sale | 1,500 | 9.52 | 14,280 |
| 2017-02-06 | Leuthner Brian A (President and CEO) | Sale | 1,500 | 9.52 | 14,280 |
| 2017-02-03 | Leuthner Brian A (President and CEO) | Sale | 1,500 | 9.69 | 14,535 |
| 2017-02-02 | Leuthner Brian A (President and CEO) | Sale | 1,500 | 9.61 | 14,415 |
| 2017-02-01 | Leuthner Brian A (President and CEO) | Sale | 1,500 | 9.38 | 14,070 |
| 2017-01-23 | Macdonald R. Loch (Chief Scientific Officer) | Option Ex | 25,000 | 2.04 | 51,000 |
| 2016-12-01 | Leuthner Brian A (President and CEO) | Sale | 7,500 | 11.60 | 87,000 |
| 2016-10-03 | Leuthner Brian A (President and CEO) | Sale | 7,500 | 10.25 | 76,845 |
| 2016-08-08 | Middlekauff W Bradford (Senior VP, GC and Secretary) | Buy | 143 | 9.43 | 1,348 |
| 2016-08-05 | Middlekauff W Bradford (Senior VP, GC and Secretary) | Buy | 9,857 | 9.48 | 93,444 |
| 2016-08-01 | Leuthner Brian A (President and CEO) | Sale | 7,500 | 9.54 | 71,580 |
| 2016-06-16 | Vaish Renu (V.P., Global Reg. Affairs) | Option Ex | 10,000 | 5.13 | 51,300 |
| 2016-03-11 | Loughlin James J (Director) | Buy | 3,000 | 7.62 | 22,875 |
| 2016-03-11 | Healy James | Buy | 541,343 | 7.30 | 3,951,803 |
| 2015-10-06 | Vaish Renu (V.P., Global Reg. Affairs) | Buy | 350 | 11.00 | 3,850 |
| 2015-10-06 | Faleck Herbert J (Chief Medical Officer) | Buy | 500 | 11.00 | 5,500 |
| 2015-10-06 | Einhorn Andrew J. (Chief Financial Officer) | Buy | 45,000 | 11.00 | 495,000 |
| 2015-10-06 | Spiegel Robert J. | Buy | 3,000 | 11.00 | 33,000 |
| 2015-10-06 | Hove Anders D | Buy | 450,000 | 11.00 | 4,950,000 |
| 2015-10-06 | Loughlin James J | Buy | 7,000 | 11.00 | 77,000 |
| 2015-10-06 | Barer Sol J | Buy | 45,000 | 11.00 | 495,000 |
| 2015-10-06 | Healy James | Buy | 450,000 | 11.00 | 4,950,000 |
| 2015-10-06 | Marchio Albert N Ii (Chief Acct. & Op., Asst. Sec.) | Buy | 100 | 11.00 | 1,100 |
Insider trading activities including stock purchases, stock sales, and option exercises of PDSB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pds Biotechnology Corp (symbol PDSB, CIK number 1472091) see the Securities and Exchange Commission (SEC) website.